China Arrests GM, Others Of Maker Of Tainted Human Rabies Vaccine
This article was originally published in PharmAsia News
Chinese authorities arrested three Dalian Jingang-Andi Bio-products employees, including two senior executives, for alleged fraud in producing a human rabies vaccine containing a banned ingredient. Arrested were the company's general manager, his deputy and a purchasing agent. China's State FDA requested the arrests after the firm was found to have deliberately included nucleic acid in the anti-rabies compound over a five-month period last year. Authorities also ordered confiscated the company's earnings from the 360,200 doses of the vaccine that have been recalled. (Click here for more
You may also be interested in...
Two leading, independent bodies of French scientists, doctors and pharmacists are calling for OTC drugs containing pseudoephedrine to be reverse-switched to prescription-only status over safety fears.
COVID-19 has shifted consumer health behaviour towards prevention and general wellbeing. However, finding out what consumers actually want and need is still the essence of good OTC innovation, according to Stada Arzneimittel's new vice president of consumer healthcare product development Steve Makin.
Swiss biotech Molecular Partners will receive upfront payment of CHF 60m, including equity.